Literature DB >> 11113677

Optimal conduit size for extracardiac Fontan operation.

V Alexi-Meskishvili1, S Ovroutski, P Ewert, I Dähnert, F Berger, P E Lange, R Hetzer.   

Abstract

BACKGROUND: Lack of conduit growth potential and thrombogenicity are the main drawbacks of the extracardiac Fontan operation (ECFO). Optimal size of the conduit according to the patients age and inferior vena cava diameter has not been established.
OBJECTIVES: We set out to ascertain whether the optimal dimensions of the conduit could be determined before an ECFO.
METHODS: Actual and expected age-related inferior vena cava diameters were compared with the extracardiac conduit diameter in 20 patients after ECFO. In 50 other pediatric and adult patients, the distance between intrapericardial part of the inferior vena cava and the undersurface of the right pulmonary artery (IVC-RPA) was measured. Cases of conduit thrombosis were analyzed.
RESULTS: The actual diameter of the inferior vena cava was variable and has a weak correlation with anthropometric data and expected diameter (R=0.07-0.23, P=0.32-0.76). The IVC-RPA distance correlated with height (R=0.87, P=0.0001), but was also variable. At the age of 2-4 years and body weight 12-15 kg IVC diameter and IVC-RPA distance are equal to 60-80% of adult values. Conduit thrombosis developed in two patients with unfavorable Fontan hemodynamics and oversized conduits.
CONCLUSIONS: Considering the inferior vena cava size, ECFO may be performed at the age of 2-3 years and at a body weight 12-15 kg, when a hemodynamically optimal almost adult sized conduit can be implanted. Optimization of the conduit is necessary on the basis of the actual inferior vena cava diameter and IVC-RPA distance. Anticoagulation postoperatively should be considered to prevent conduit thrombosis in patients with suboptimal Fontan circulation

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11113677     DOI: 10.1016/s1010-7940(00)00593-5

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  20 in total

Review 1.  Tissue-engineered vascular grafts for use in the treatment of congenital heart disease: from the bench to the clinic and back again.

Authors:  Joseph T Patterson; Thomas Gilliland; Mark W Maxfield; Spencer Church; Yuji Naito; Toshiharu Shinoka; Christopher K Breuer
Journal:  Regen Med       Date:  2012-05       Impact factor: 3.806

2.  The Fontan extracardiac conduit: one size does not fit all.

Authors:  Frank Cetta; Harold M Burkhart
Journal:  Transl Pediatr       Date:  2018-07

3.  Pulmonary hepatic flow distribution in total cavopulmonary connections: extracardiac versus intracardiac.

Authors:  Lakshmi P Dasi; Kevin Whitehead; Kerem Pekkan; Diane de Zelicourt; Kartik Sundareswaran; Kirk Kanter; Mark A Fogel; Ajit P Yoganathan
Journal:  J Thorac Cardiovasc Surg       Date:  2011-01       Impact factor: 5.209

Review 4.  Evaluating the Longevity of the Fontan Pathway.

Authors:  John M Kelly; Gabriel J M Mirhaidari; Yu-Chun Chang; Toshiharu Shinoka; Christopher K Breuer; Andrew R Yates; Kan N Hor
Journal:  Pediatr Cardiol       Date:  2020-11-08       Impact factor: 1.655

5.  Relation Between Exercise Capacity and Extracardiac Conduit Size in Patients with Fontan Circulation.

Authors:  Sang-Yun Lee; Mi-Kyoung Song; Gi-Beom Kim; Eun-Jung Bae; Seong-Ho Kim; So-Ick Jang; Sung-Kyu Cho; Jae-Gun Kawk; Woong-Han Kim; Chang-Ha Lee; Hyun-Jeong Kim; Jayoun Kim
Journal:  Pediatr Cardiol       Date:  2019-08-31       Impact factor: 1.655

6.  Oversized Biodegradable Arterial Grafts Promote Enhanced Neointimal Tissue Formation.

Authors:  Cameron Best; Takuma Fukunishi; Joseph Drews; Ramak Khosravi; Kan Hor; Nathan Mahler; Tai Yi; Jay D Humphrey; Jed Johnson; Christopher K Breuer; Narutoshi Hibino
Journal:  Tissue Eng Part A       Date:  2018-05-10       Impact factor: 3.845

Review 7.  Translational Challenges in Cardiovascular Tissue Engineering.

Authors:  Maximilian Y Emmert; Emanuela S Fioretta; Simon P Hoerstrup
Journal:  J Cardiovasc Transl Res       Date:  2017-03-09       Impact factor: 4.132

8.  Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling.

Authors:  Jason D Roh; Rajendra Sawh-Martinez; Matthew P Brennan; Steven M Jay; Lesley Devine; Deepak A Rao; Tai Yi; Tamar L Mirensky; Ani Nalbandian; Brooks Udelsman; Narutoshi Hibino; Toshiharu Shinoka; W Mark Saltzman; Edward Snyder; Themis R Kyriakides; Jordan S Pober; Christopher K Breuer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-05       Impact factor: 11.205

9.  Role of surgeon intuition and computer-aided design in Fontan optimization: A computational fluid dynamics simulation study.

Authors:  Yue-Hin Loke; Byeol Kim; Paige Mass; Justin D Opfermann; Narutoshi Hibino; Axel Krieger; Laura Olivieri
Journal:  J Thorac Cardiovasc Surg       Date:  2020-01-08       Impact factor: 5.209

10.  Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model.

Authors:  Matthew P Brennan; Alan Dardik; Narutoshi Hibino; Jason D Roh; Gregory N Nelson; Xenophon Papademitris; Toshiharu Shinoka; Christopher K Breuer
Journal:  Ann Surg       Date:  2008-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.